B7-33 (6mg) is a synthetic peptide supplied exclusively for controlled laboratory research, analytical evaluation, and in-vitro experimentation. It may be studied in assays involving relaxin family peptide receptor 1 (RXFP1), receptor-ligand interactions, signal-transduction measurements, and peptide structure-activity relationships.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY."
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
B7-33 is a synthetic peptide supplied exclusively for controlled laboratory research, analytical evaluation, and in-vitro experimentation. It may be studied in assays involving relaxin family peptide receptor 1 (RXFP1), receptor-ligand interactions, signal-transduction measurements, and peptide structure-activity relationships.
Research environments may use B7-33 as a reference material in controlled in-vitro assays involving RXFP1. Appropriate experimental controls are necessary when examining concentration-dependent assay responses, receptor selectivity, analytical identity, or signaling measurements.
For laboratory research use only. Not for human or animal consumption. Not for diagnostic, therapeutic, veterinary, food, cosmetic, or dietary-supplement use.
B7-33 (6mg) – Research Specifications:
| Compound | B7-33 |
| Quantity | 6mg per vial |
| Compound Type | Synthetic research peptide |
| Research Classification | Laboratory research material |
| Form | Lyophilized peptide powder |
| Purity / Identity | Refer to the lot-specific Certificate of Analysis |
| Analytical Documentation | Lot-specific documentation available through the COA Library |
| Storage Conditions | Store sealed under controlled laboratory conditions and protect from heat, light, and moisture |
| Research Use Only | Not for human or animal consumption |
B7-33 is a synthetic peptide studied in controlled laboratory systems involving relaxin family peptide receptor 1. RXFP1 is a receptor used in experimental research examining ligand recognition, receptor activation, downstream signal measurement, and structure-activity relationships.
Laboratory studies may compare B7-33 with other reference compounds to evaluate receptor selectivity, assay behavior, peptide stability, or analytical characteristics. These studies should use validated laboratory methods, appropriate controls, and documented experimental conditions.
B7-33 may also be examined through analytical techniques used to evaluate peptide identity and purity. Lot-specific results should be reviewed through the applicable Certificate of Analysis.
Important Research Notice: Nordsci research materials are accompanied by lot-specific analytical documentation. Laboratories should review the applicable Certificate of Analysis before incorporating the material into an experimental workflow.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT INTENDED FOR DIAGNOSTIC, THERAPEUTIC, VETERINARY, FOOD, COSMETIC, OR DIETARY-SUPPLEMENT USE.
B7-33 may be used in controlled in-vitro assays examining interactions with RXFP1. Research endpoints may include receptor binding, activation measurements, selectivity comparisons, or downstream signal detection.
Laboratory researchers may use receptor-based assay systems to examine signaling pathways associated with extracellular matrix biology. B7-33 should be treated as an experimental variable within properly controlled research designs, without extrapolating in-vitro observations to human or animal outcomes.
B7-33 may be included in mechanistic laboratory studies examining receptor-mediated pathways associated with matrix turnover and cellular signaling. Such investigations require defined assay parameters, appropriate comparators, and independently documented results.
In-vitro research may examine the relationship between RXFP1-associated signaling and laboratory markers used in cellular pathway analysis. B7-33 is supplied as a research material for mechanistic investigation only and is not intended for studies involving therapeutic use.
B7-33 (6mg) should be handled by qualified laboratory personnel using established procedures for peptide research materials. Laboratories should document storage conditions, material handling, analytical methods, assay parameters, controls, and study results.
Protocol Design Considerations: Experimental findings may vary according to assay format, concentration, receptor expression, cell model, analytical method, environmental conditions, and other controlled variables. Researchers are responsible for validating their methods and determining whether the material is appropriate for a specific in-vitro research protocol.
No dosing, administration, preparation, clinical, or veterinary guidance is provided.
This information is provided exclusively for laboratory research reference. All work involving B7-33 should be conducted by qualified personnel in appropriately controlled research environments.
Lot-specific analytical documentation for B7-33 is available through the Nordsci Peptides COA Library. The applicable Certificate of Analysis contains the analytical information reported for the corresponding lot and may be retained as part of laboratory traceability records.
Researchers should review the applicable COA before use and independently determine whether the documented specifications meet the requirements of their analytical method or research protocol.
Nordsci Peptides supplies B7-33 (6mg) exclusively as a laboratory research material. Laboratories evaluating peptide suppliers should review lot-specific analytical documentation, material identity information, storage requirements, and traceability records before purchasing.
The availability of a product or Certificate of Analysis does not indicate approval for clinical, diagnostic, therapeutic, veterinary, food, cosmetic, or dietary-supplement use.
IMPORTANT: B7-33 (6mg) is supplied exclusively for laboratory research and in-vitro analytical use. It is not for human or animal consumption. It is not intended for diagnostic, therapeutic, veterinary, food, cosmetic, or dietary-supplement use. Researchers are responsible for compliance with applicable institutional and regulatory requirements.
